Literature DB >> 28131025

An ultra performance liquid chromatography-tandem mass spectrometry method for the therapeutic drug monitoring of isavuconazole and seven other antifungal compounds in plasma samples.

Balthazar Toussaint1, Fanny Lanternier2, Christian Woloch1, Denis Fournier1, Manon Launay1, Eliane Billaud1, Eric Dannaoui3, Olivier Lortholary2, Vincent Jullien4.   

Abstract

A new analytical method was developed for the routine Therapeutic Drug Monitoring of 8 antifungals compounds in 50μL of plasma: isavuconazole (ISZ), voriconazole (VRZ), posaconazole (PSZ), fluconazole (FCZ), caspofungin (CSF), flucytosine (5FC), itraconazole (ITZ) and its metabolite OH-itraconazole (OH-ITZ). After adding 50μL of the internal standard, which consisted in a mixture of the deuterated isotopes of the quantified compounds, the sample treatment consisted in a simple protein precipitation with 400μL of acetonitrile. Five microliters of the supernatant were directly injected into the chromatographic system. The chromatographic separation was performed with a Waters C18-BEH column and a mobile phase consisting in a mixture of water and acetonitrile, both containing 0.1% of formic acid. The total run time was 3min and the detection of the analytes was performed by electrospray ionization in a positive mode using selected reaction monitoring. Intra and inter-day precision and inaccuracy were <15% over the calibration ranges that were determined according to their clinical relevance: 0.20-20.0mg/L for ISZ, VRZ, PSZ, ITZ, and OH-ITZ; 0.50-50.0mg/L for FCZ and CSF; 2.00-200mg/L for 5FC. This simple and fast method was found suitable for routine therapeutic drug monitoring.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antifungal drugs; Liquid chromatography; Tandem mass spectrometry; Therapeutic drug monitoring

Mesh:

Substances:

Year:  2017        PMID: 28131025     DOI: 10.1016/j.jchromb.2017.01.036

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  5 in total

1.  Isavuconazole Diffusion in Infected Human Brain.

Authors:  Claire Rouzaud; Vincent Jullien; Anne Herbrecht; Bruno Palmier; Simona Lapusan; Marjolaine Morgand; Romain Guéry; Amélie Dureault; François Danion; Stéphanie Puget; Lauriane Goldwirt; Fanny Lanternier; Olivier Lortholary
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

Review 2.  Review of Chromatographic Methods Coupled with Modern Detection Techniques Applied in the Therapeutic Drugs Monitoring (TDM).

Authors:  Tomasz Tuzimski; Anna Petruczynik
Journal:  Molecules       Date:  2020-09-03       Impact factor: 4.411

3.  Implementation of Isavuconazole in a Fluorescence-Based High-Performance Liquid Chromatography Kit Allowing Simultaneous Detection of All Four Currently Licensed Mold-Active Triazoles.

Authors:  René Jørgensen; Siri Rytcher Andersen; Karen Marie Thyssen Astvad; Maiken Cavling Arendrup
Journal:  mSphere       Date:  2017-05-10       Impact factor: 4.389

4.  Interlaboratory Analysis of Isavuconazole Plasma Concentration Assays Among European Laboratories.

Authors:  Federico Pea; Robert Krause; Carsten Müller; Benjamin Hennart; Malcolm Richardson; Andreas Meinitzer; Martin H J Wiesen; Tatiana Wiktorowicz; Jochen Spickermann; Anne S Henriksen
Journal:  Ther Drug Monit       Date:  2019-10       Impact factor: 3.681

5.  In Vivo Efficacy of Voriconazole in a Galleria mellonella Model of Invasive Infection Due to Azole-Susceptible or Resistant Aspergillus fumigatus Isolates.

Authors:  Sana Jemel; Jacques Guillot; Kalthoum Kallel; Grégory Jouvion; Elise Brisebard; Eliane Billaud; Vincent Jullien; Françoise Botterel; Eric Dannaoui
Journal:  J Fungi (Basel)       Date:  2021-11-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.